We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $783M
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P
Everpure Inc
P
+$3.43M

Top Sells

Rank Stock Value
1
CPRX
Catalyst Pharmaceutical
CPRX
+$11.2M
2
BAP icon
Credicorp
BAP
+$9.17M
3
NXT icon
Nextpower Inc. Common Stock
NXT
+$6.93M
4
XP icon
XP
XP
+$6.54M
5
STRL icon
Sterling Infrastructure
STRL
+$5.21M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDN icon
376
Intellicheck
IDN
$48M
$69.7K 0.01%
+16,989
New +$102K
APPN icon
377
Appian
APPN
$2.73B
$68.7K 0.01%
2,999
– –
FINW icon
378
FinWise Bancorp
FINW
$176M
$47.9K 0.01%
3,300
-10,037
-75% -$149K
FSBC icon
379
Five Star Bancorp
FSBC
$1.1B
$46.1K 0.01%
946
– –
PAYO icon
380
Payoneer
PAYO
$2.41B
$12.5K ﹤0.01%
+1,754
New +$9.6K
SHO icon
381
Sunstone Hotel Investors
SHO
$2.05B
$7.83K ﹤0.01%
+684
New +$7.18K
ENSG icon
382
The Ensign Group
ENSG
$10.2B
$6.09K ﹤0.01%
38
– –
VSXY
383
Victoria's Secret
VSXY
$6.18B
$3.67K ﹤0.01%
44
– –
HAE icon
384
Haemonetics
HAE
$4.9B
$2.48K ﹤0.01%
33
– –
GVA icon
385
Granite Construction
GVA
$5.12B
$2.37K ﹤0.01%
+15
New +$2.04K
FN icon
386
Fabrinet
FN
$13.7B
$2.25K ﹤0.01%
4
-360
-99% -$232K
FORM icon
387
FormFactor
FORM
$8.71B
$2.24K ﹤0.01%
+14
New +$1.86K
AMBA icon
388
Ambarella
AMBA
$2.95B
$2.23K ﹤0.01%
+26
New +$1.79K
WK icon
389
Workiva
WK
$3.98B
$1.99K ﹤0.01%
+41
New +$2.11K
NSSC icon
390
Napco Security Technologies
NSSC
$1.29B
$1.9K ﹤0.01%
+50
New +$1.99K
RELY icon
391
Remitly
RELY
$4.6B
$1.86K ﹤0.01%
+83
New +$1.7K
APPF icon
392
AppFolio
APPF
$7.78B
$1.76K ﹤0.01%
+11
New +$1.76K
AAPL icon
393
Apple
AAPL
$4.92T
$289 ﹤0.01%
+1
New +$286
ADBE icon
394
Adobe
ADBE
$100B
– –
-200
Closed -$48.6K
ADMA icon
395
ADMA Biologics
ADMA
$2B
– –
-11,924
Closed -$107K
AHRT
396
AH Realty Trust
AHRT
$465M
– –
-197,137
Closed -$1.08M
APAM icon
397
Artisan Partners
APAM
$2.59B
– –
-38
Closed -$1.38K
AU icon
398
AngloGold Ashanti
AU
$51.8B
– –
-2,335
Closed -$227K
BAP icon
399
Credicorp
BAP
$30.5B
– –
-27,049
Closed -$9.17M
BDTX icon
400
Black Diamond Therapeutics
BDTX
$111M
– –
-305,276
Closed -$650K
14 15
16
17 18

Similar funds

CC
Converium Capital Montreal $783M AUM
CCG
Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
LF
Lee Financial Dallas, Texas $783M AUM 23.98% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $783M AUM 19.25% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
CWP
CFM Wealth Partners Austin, Texas $783M AUM 47.07% 1-Year Est. Return

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.